Hikma Pharmaceuticals (HIK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,958.00p
   
  • Change Today:
    -1.00p
  • 52 Week High: 2,205.00p
  • 52 Week Low: 1,722.00p
  • Currency: UK Pounds
  • Shares Issued: 221.89m
  • Volume: 159,271
  • Market Cap: £4,344.51m
  • RiskGrade: 125

Wednesday broker round-up

By Caoimhe Toman

Date: Wednesday 02 Dec 2020

LONDON (ShareCast) - (Sharecast News) - Royal Dutch Shell A: JP Morgan upgrades to overweight with a target price of 1,700p.



Boku: Berenberg reiterates buy with a target price of 160p.

Hummingbird Resources: Canaccord reiterates buy with a target price of 55p.

Energean: Peel Hunt reiterates buy with a target price of 1,000p.

IWG: Peel Hunt reiterates hold with a target price of 360p.

Barclays: Deutsche Bank reiterates buy with a target price of 165p.

HSBC: Deutsche Bank reiterates sell with a target price of 350p.

Weir Group: Barclays reiterates neutral with a target price of 2,000p.

Hikma Pharmaceuticals: Citigroup reiterates buy with a target price of 3,030p.

Royal Dutch Shell B: JP Morgan upgrades to overweight with a target price of 1,700p.

Centamin: RBC Capital Markets reiterates sector perform with a target price of 145p.

Hyve Group: Liberum reiterates hold with a target price of 80p.

Email this article to a friend

or share it with one of these popular networks:


Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

HIK Market Data

Currency UK Pounds
Share Price 1,958.00p
Change Today -1.00p
% Change -0.05 %
52 Week High 2,205.00p
52 Week Low 1,722.00p
Volume 159,271
Shares Issued 221.89m
Market Cap £4,344.51m
RiskGrade 125

HIK Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
46.24% below the market average46.24% below the market average46.24% below the market average46.24% below the market average46.24% below the market average
33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average33.33% below the sector average
Price Trend
47.54% above the market average47.54% above the market average47.54% above the market average47.54% above the market average47.54% above the market average
81.48% above the sector average81.48% above the sector average81.48% above the sector average81.48% above the sector average81.48% above the sector average
Income
19.25% above the market average19.25% above the market average19.25% above the market average19.25% above the market average19.25% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Growth
36.24% below the market average36.24% below the market average36.24% below the market average36.24% below the market average36.24% below the market average
23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average23.53% below the sector average

What The Brokers Say

Strong Buy 4
Buy 2
Neutral 4
Sell 1
Strong Sell 0
Total 11
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

HIK Dividends

  Latest Previous
  Final Interim
Ex-Div 21-Mar-24 10-Aug-23
Paid 03-May-24 15-Sep-23
Amount 47.00¢ 25.00¢

Trades for 24-May-2024

Time Volume / Share Price
16:35 101,355 @ 1,958.00p
16:35 280 @ 1,958.00p
16:35 511 @ 1,958.00p
16:35 525 @ 1,958.00p
16:35 187 @ 1,958.00p

HIK Key Personnel

CEO Riad Mishlawi

Top of Page